FATE icon

Fate Therapeutics
FATE

Overview Fund Activity

136 hedge funds and large institutions have $88.5M invested in Fate Therapeutics in 2025 Q2 according to their latest regulatory filings, with 28 funds opening new positions, 44 increasing their positions, 40 reducing their positions, and 21 closing their positions.

Holders
136
Holders Change
+6
Holders Change %
+4.62%
% of All Funds
1.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
44
Reduced
40
Closed
21
Calls
$154K
Puts
$40K
Net Calls
+$114K
Net Calls Change
+$56K

Top Buyers

1
Millennium Management
1
Millennium Management
New York
$985K
2
Jane Street
2
Jane Street
New York
$522K
3
AQR Capital Management
3
AQR Capital Management
Connecticut
$948K
4
GCP
4
GSA Capital Partners
United Kingdom
$288K
5
Citadel Advisors
5
Citadel Advisors
Florida
$5.09M

Top Sellers

1
SSA
1
Schonfeld Strategic Advisors
New York
$1.04M
2
JPMorgan Chase & Co
2
JPMorgan Chase & Co
New York
$65.6K
3
Vanguard Group
3
Vanguard Group
Pennsylvania
$9.82M
4
O
4
OrbiMed
New York
$0
5
Jacobs Levy Equity Management
5
Jacobs Levy Equity Management
New Jersey
$1.36M
Name Market Value Shares Shares
Change 		Shares
Change %
WA
151
Wilshire Advisors
California
– – -4,083 Closed
CCM
152
Coldstream Capital Management
Washington
– – -686 Closed
CA
153
CoreCap Advisors
Michigan
– – -255 Closed
LWMI
154
Legacy Wealth Management (Idaho)
Idaho
– – -115 Closed
RIL
155
Rothschild Investment LLC
Illinois
– – -70 Closed
C
156
Covestor
United Kingdom
– – -31 Closed
Group One Trading
157
Group One Trading
Illinois
– – – –
AW
158
Avion Wealth
Texas
$0 625 +625 New
3 4 5 6
7